Mutation-guided therapeutics

Science. 2022 Apr 8;376(6589):147. doi: 10.1126/science.abo4237. Epub 2022 Apr 7.

Author

Jacqueline Douglass¹

Affiliation

¹ Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

PMID: 35389812
DOI: 10.1126/science.abo4237

Abstract

Development of bispecific antibodies to target mutant peptides in cancer.

MeSH terms

Antibodies, Bispecific* / therapeutic use
Humans
Immunotherapy
Mutation
Neoplasms* / drug therapy
Neoplasms* / genetics

Substances

Antibodies, Bispecific